e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Serial blood eosinophils and clinical characteristics in COPD patients without a history of asthma or atopy
A. Chis (Cluj-Napoca, Romania), M. Chasseriaud (Cluj-Napoca, Romania), D. Todea (Cluj-Napoca, Romania), M. Man (Cluj-Napoca, Romania), R. Rajnoveanu (Cluj-Napoca, Romania), C. Pop (Cluj-Napoca, Romania)
Source:
International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Session:
COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Session type:
Thematic Poster
Number:
4387
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Chis (Cluj-Napoca, Romania), M. Chasseriaud (Cluj-Napoca, Romania), D. Todea (Cluj-Napoca, Romania), M. Man (Cluj-Napoca, Romania), R. Rajnoveanu (Cluj-Napoca, Romania), C. Pop (Cluj-Napoca, Romania). Serial blood eosinophils and clinical characteristics in COPD patients without a history of asthma or atopy. 4387
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Associations between blood and sputum eosinophils and clinical features of mild-to-moderate COPD
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities.
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018
Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD
Source: Eur Respir J, 50 (5) 1701162; 10.1183/13993003.01162-2017
Year: 2017
Blood vs sputum eosinophils as predictors of exacerbations in a cohort of severe asthmatics
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018
Clinical factors associated with baseline blood eosinophils among patients with asthma or COPD: NOVELTY study
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020
The usefulness of blood eosinophil count and FeNO to predict sputum eosinophilia in the diagnosis of severe eosinophilic asthma
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019
Sputum analysis reveals eosinophilic inflammation in difficult-to-control asthma patients with low blood eosinophils and FENO.
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020
Predictors of sputum eosinophilia in severe asthma
Source: Virtual Congress 2020 – Clinical parameters in severe asthma
Year: 2020
Pharmacodynamic effect of benralizumab on blood basophils and serum biomarkers in adults with COPD with sputum eosinophilia
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015
The clinical, spirometric and cytological profiles of exacerbations in poorly controlled severe persistent asthmatics
Source: Annual Congress 2007 - Towards controlling severe asthma
Year: 2007
Sputum eosinophilia in the diagnosis and management of asthma of moderate severity in adults
Source: Eur Respir J 2007; 30: Suppl. 51, 587s
Year: 2007
Airway eosinophilia is not related to clinical and functional findings in a large group of severe refractory asthmatics
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers
vs
induced sputum
Year: 2006
Airway eosinophilia in severe asthma is associated with smoking history
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018
Stability of blood eosinophils over time in patients with asthma
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021
The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020
Cytokine profile in sputum from non-infective exacerbation of COPD and non-atopic asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 252s
Year: 2002
The relationship between blood neutrophils, blood eosinophils and exacerbations of COPD – Results from the TIE-study
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Different features between subjects with asthma diagnosis and with only asthmatic symptoms
Source: Annual Congress 2010 - Methods in respiratory epidemiology
Year: 2010
The prevalences of asthma and atopy in bronchiectasis patients
Source: Eur Respir J 2006; 28: Suppl. 50, 322s
Year: 2006
Blood biomarkers in asthma and COPD
Source: International Congress 2017 – PG6 Assessing and monitoring airway inflammation in asthma and chronic obstructive pulmonary disease
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept